Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04297579
Other study ID # RECHMPL20_0063
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 1984
Est. completion date May 1, 2020

Study information

Verified date June 2020
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Depending on its dimensions, it is difficult to predict if a congenital nevi of the lower limb can be surgically removed by a unique simple procedure or by a complex procedure (expander, skin graft etc..), with a good result.

This study retrospectively reviewed the practice of our team of surgeons depending on the size of the naevus to reveal a dimension threshold that can be used in the future to help to choose between a simple or a complex procedure.


Description:

Retrospective study using medical file data only. No intervention nor phone call etc.. to the patients or their parents.


Recruitment information / eligibility

Status Completed
Enrollment 176
Est. completion date May 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion criteria:

- Child + congenital nevi in the lower limb + had removal surgery

Exclusion criteria:

- More than one congenital nevi in the lower limb.

Study Design


Related Conditions & MeSH terms

  • Congenital Melanocytar Nevi in the Lower Limb
  • Nevus

Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Nevi Estimated Size Nevi Estimated Size (centimeters) within three weeks after surgery
Secondary post-operative complications depending on the initial size of the naevus post-operative complications depending on the initial size of the naevus : percentage of complication rate assessed within 6 months after surgery